SlideShare a Scribd company logo
Meniere’s disease(sbo-3) 
Meniere’s disease is a disorder characterized by spontaneous attacks of vertigo ,with associated 
fluctuating sensorineural hearing loss ,tinnitus &aural fullness .It is a common cause of the syndrome 
of spontaneous vertigo. 
Aetiology Meniere’s disease is said to be idiopathic,although a variety of predisposing factor have 
been identified.Overproduction or malabsortion of endolymph resulting endolymphatic 
hypertension ,in tern endolymphatic hydrops. 
Many different inner ear disease disease mumps,csom,trauma cogan syndrome,autoimmunity to the 
inner ear antigens. 
Pathophysiology:Periodic ruptures of the membranous labyrinth which result in leakage of the 
potassium-rich endolymph into perilymph are thought to be responsible for producing meniere’s 
attacks. 
Initial excitation of the hair cells as a result of the increased potassium concentration, 
Subsequent paretic phase is thought blockade of neurotransmitter release. 
Healing of the rupture allows restitution of the chemical composition of the endolymph & 
perilymph resulting in termination of the attack& improvement in vestibular & auditory function. 
The gradual deteriotion in inner ear function result from the effects of repeated ruptures. 
Clinical manifestations 
Recurrent attacks of spontaneous vertigo with nausea vomiting,attack are herald by lateralized low 
frequency hearing loss,tinnitus &aural fullness. 
Following onset ,the vertigo typically increases in intensity over a perioid of minutes then usually 
lasts for several hours.The hearing impairment &tinnitus may persist for days.Patient may have 
postural imbalance for several days. 
Typical attack has three phase;Irritative phase; nystagmus horizontal,beat towards the affected ear. 
Paretic phase; nystagmus beats away from the affected ear,last for several hours.Recovery phase 
;nystagmus towards again affected side. 
In the early stage of the disease ,most patients are well between the attacks.As the disease 
progress ,patients may have persistent hearing loss,tinnitus&postural imbalance. 
Later stage of disease,some patients develop drop attacks(tumarkin or otolithic crises).The patient 
drops to ground without warning(patient experience some external force pushed to the ground.)
Diagnosis of meneire’s disease: 
American Academy of Otolaryngology –head & neck surgery has published diagnostic guidelines for 
Meneire’s disease. 
Definite Meneire’s disease;two or more spontaneous attack of vertigo(each lasting 20minute or 
Longer)Hearing loss documented by PTA at least one occasion,tinnitus or aural fullness on the 
affected side. 
Probable Meneire’s disease;two or more spontaneous attack of vertigo with unilateral loss,tinnitus, 
Or aural fullness all at same time. 
A possible meneire’s disease;two or more spontaneous attack of vertigo,no auditory symptom 
during attack. 
In early stages of Meniere’s disease,vestibular &auditory function tests are often completely normal 
between attacks.A fluctuating low-frequency sensorineural hearing loss may be seen & is suggestive 
of the diagnosis of the early stage of the disease. As the disease progresses,all frequencies are 
affected resulting in a flat sensorineural hearing loss that is at least moderate in severity. 
Electrocochleograpgy; most sensitive & specific for meniere’s disease when tone-burst &click stimuli 
are used. Recorded transtympanically at the promontory. Giving 4gm of nacl for 3days prior to the 
electrocochleogram may increase the sensitivity. 
Management options: aim to decrease the production or accumulation of endolymph.Strict sodium 
restriction (so that uninary sodium is less than 50mmol/day) &diuretic can be effective in reducing 
the frequency of vertigo. 
Surgery; Endolymphatic sac surgery,selective vestibular neurectomy.labyrinthectomy with cochlear 
implantation. 
Recently intra tympanic inj. Of gentamycin may be effective to control severe intractable vertigo in 
most patients. 
Outcomes &complications; the natural history of meniere’s disease is variable.Attacks may occur 
days ,months ,even year apart, with little or no warning. 
In most patients only one ear is affected in early stage of disease, unfortunately the second ear 
involved in about half of the patients . 
Treatment of meniere’s disease(p 3798) 
The treatment of meniere’s disease should be preceded by diagnosis on the basis of strict criteria& 
after exclusion of retrocochlear pathology.
1)General measures:Level of anxiety correlates with the severity of symptoms in the patients with 
Meniere’s disease,it is postulated that stress may contribute via autonomic mechanisms in the 
genesis of endolymphatic hydrops. 
Increase prevalence for both inhalant & food allergies in patients with meniere’s diseae& it has been 
suggested that allergy immunotherapy & food elimination may be benefit in these cases. 
2) Diet: to restrict salt intake to 1mg or 1.5 -2mg /day in order to address endolymphatic hydrops. 
3)Drug therapy:Drug therapy for Meniere’s disease may include, 
a)Acute vestibular symptoms suppression by anticholinergic ,antihistaminic,calcium channel 
antagonist. 
b)Drug that aim to influence endolymphatic hydrops which include diuretics & betahistine. 
c)Suppression of immunological reactions with steroids or methotrexate. 
d)Deastruction of the vestibular end organ by intratympanic injection of aminoglycosides. 
Diuretics may be effective in the long term control of vertigo but not of cochlear symptoms. 
Dyazide has been reported as effective in controlling vertigo. 
Betahistine is a histaminic analogue with weak agonistic of both H1 & H2 ,moderate antagonistic 
action of H3 histaminic receptors. 
a) A reduction of the symmetric functioning of the vestibular end organ. 
b) Improved microvascular circulation in the stria vascularis of the cochlear. 
c) Inhibition of the activity in the vestibular nuclei. 
d) Less alertness effects on alertness through cerebral H1 receptors. 
Suppression of immunogical reaction:oral recommended treatments include high doses of 
prednisolone for one month with slow tapering over 4 to 6 months. 
Intratympanic injection of aminoglycoside.

More Related Content

Similar to Meniere's disease(sbo 3)

Meniere's disease
Meniere's diseaseMeniere's disease
Meniere's disease
Azadmeena7
 
Meniere
MeniereMeniere
Kmenieres
KmenieresKmenieres
Meniere's Disease
Meniere's DiseaseMeniere's Disease
Diseases of the inner ear
Diseases of the inner earDiseases of the inner ear
Diseases of the inner ear
Rahman1973
 
Meniere's disease
Meniere's  diseaseMeniere's  disease
Meniere's disease
Saef Moniem
 
MENIERES DISEASE.pptx
MENIERES DISEASE.pptxMENIERES DISEASE.pptx
MENIERES DISEASE.pptx
ssuserd9e4ec
 
Inner Ear.pptx
Inner Ear.pptxInner Ear.pptx
Inner Ear.pptx
ManjurRahim
 
Meniere disease
Meniere diseaseMeniere disease
Meniere disease
humra shamim
 
Meniere’s disease
Meniere’s diseaseMeniere’s disease
Meniere’s disease
Joyce Mwatonoka
 
Acute otitis media.pptx
Acute otitis media.pptxAcute otitis media.pptx
Acute otitis media.pptx
ahmedmohamoud23
 
Meniere’s disease
Meniere’s diseaseMeniere’s disease
Meniere’s disease
DrDeepa Grover
 
Inner ear Disorder : Nursing care
Inner ear Disorder : Nursing careInner ear Disorder : Nursing care
Inner ear Disorder : Nursing care
V4Veeru25
 
Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR.
Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR. Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR.
Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR.
docprakashh
 
ENT MRCGP Qs
ENT MRCGP QsENT MRCGP Qs
ENT MRCGP Qs
ssnsharifa
 
MS Auditory Disorders.pptx
MS Auditory Disorders.pptxMS Auditory Disorders.pptx
MS Auditory Disorders.pptx
ZedLopez1
 
Minere's disease.pptx
Minere's disease.pptxMinere's disease.pptx
Minere's disease.pptx
ssuser0a9d4a
 

Similar to Meniere's disease(sbo 3) (20)

Inner ear
Inner earInner ear
Inner ear
 
Meniere's disease
Meniere's diseaseMeniere's disease
Meniere's disease
 
Meniere
MeniereMeniere
Meniere
 
Kmenieres
KmenieresKmenieres
Kmenieres
 
MENIERE’S DISEASE
MENIERE’S DISEASEMENIERE’S DISEASE
MENIERE’S DISEASE
 
Meniere's Disease
Meniere's DiseaseMeniere's Disease
Meniere's Disease
 
Diseases of the inner ear
Diseases of the inner earDiseases of the inner ear
Diseases of the inner ear
 
Meniere's disease
Meniere's  diseaseMeniere's  disease
Meniere's disease
 
MENIERES DISEASE.pptx
MENIERES DISEASE.pptxMENIERES DISEASE.pptx
MENIERES DISEASE.pptx
 
Meniere’s disease mine
Meniere’s disease mineMeniere’s disease mine
Meniere’s disease mine
 
Inner Ear.pptx
Inner Ear.pptxInner Ear.pptx
Inner Ear.pptx
 
Meniere disease
Meniere diseaseMeniere disease
Meniere disease
 
Meniere’s disease
Meniere’s diseaseMeniere’s disease
Meniere’s disease
 
Acute otitis media.pptx
Acute otitis media.pptxAcute otitis media.pptx
Acute otitis media.pptx
 
Meniere’s disease
Meniere’s diseaseMeniere’s disease
Meniere’s disease
 
Inner ear Disorder : Nursing care
Inner ear Disorder : Nursing careInner ear Disorder : Nursing care
Inner ear Disorder : Nursing care
 
Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR.
Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR. Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR.
Anatomy & Physio Hearing. Clinical application. Evoked potential.ABR.
 
ENT MRCGP Qs
ENT MRCGP QsENT MRCGP Qs
ENT MRCGP Qs
 
MS Auditory Disorders.pptx
MS Auditory Disorders.pptxMS Auditory Disorders.pptx
MS Auditory Disorders.pptx
 
Minere's disease.pptx
Minere's disease.pptxMinere's disease.pptx
Minere's disease.pptx
 

More from Shekhar Krishna Debnath

Tumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodTumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodShekhar Krishna Debnath
 
Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)Shekhar Krishna Debnath
 
Branchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangiomaBranchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangiomaShekhar Krishna Debnath
 

More from Shekhar Krishna Debnath (20)

Pta(sbo 3)
Pta(sbo 3)Pta(sbo 3)
Pta(sbo 3)
 
Vertigo
VertigoVertigo
Vertigo
 
Stridor vol 1
Stridor vol  1Stridor vol  1
Stridor vol 1
 
Obstuctive sleep apnoea in children
Obstuctive sleep apnoea in childrenObstuctive sleep apnoea in children
Obstuctive sleep apnoea in children
 
Nose
NoseNose
Nose
 
Diseases of the tonsils 2
Diseases of  the tonsils 2Diseases of  the tonsils 2
Diseases of the tonsils 2
 
Disease of tonsils
Disease of tonsilsDisease of tonsils
Disease of tonsils
 
Corticosteroid in otolaryngology
Corticosteroid in otolaryngologyCorticosteroid in otolaryngology
Corticosteroid in otolaryngology
 
Viruses & antiviral agents
Viruses & antiviral agentsViruses & antiviral agents
Viruses & antiviral agents
 
Tumours of the head & neck in the childhood
Tumours of the head & neck in the childhoodTumours of the head & neck in the childhood
Tumours of the head & neck in the childhood
 
The adenoid & adenoidectomy
The adenoid & adenoidectomyThe adenoid & adenoidectomy
The adenoid & adenoidectomy
 
Otitis media with effusion
Otitis media with effusionOtitis media with effusion
Otitis media with effusion
 
Gastro oesophageal reflux & aspiration
Gastro oesophageal reflux & aspirationGastro oesophageal reflux & aspiration
Gastro oesophageal reflux & aspiration
 
Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)Fungi( all fungal sinusitis & candidiasis)
Fungi( all fungal sinusitis & candidiasis)
 
Diseases of the tonsil
Diseases of the tonsilDiseases of the tonsil
Diseases of the tonsil
 
Chronic otitis media in childhood
Chronic otitis media in childhoodChronic otitis media in childhood
Chronic otitis media in childhood
 
Branchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangiomaBranchial arch fistulae, thyroglossal duct anomalies& lymphangioma
Branchial arch fistulae, thyroglossal duct anomalies& lymphangioma
 
Antimicrobial therapy
Antimicrobial therapyAntimicrobial therapy
Antimicrobial therapy
 
Acute otitis media in children
Acute otitis media in childrenAcute otitis media in children
Acute otitis media in children
 
Physiology of swallowing
Physiology of swallowingPhysiology of swallowing
Physiology of swallowing
 

Meniere's disease(sbo 3)

  • 1. Meniere’s disease(sbo-3) Meniere’s disease is a disorder characterized by spontaneous attacks of vertigo ,with associated fluctuating sensorineural hearing loss ,tinnitus &aural fullness .It is a common cause of the syndrome of spontaneous vertigo. Aetiology Meniere’s disease is said to be idiopathic,although a variety of predisposing factor have been identified.Overproduction or malabsortion of endolymph resulting endolymphatic hypertension ,in tern endolymphatic hydrops. Many different inner ear disease disease mumps,csom,trauma cogan syndrome,autoimmunity to the inner ear antigens. Pathophysiology:Periodic ruptures of the membranous labyrinth which result in leakage of the potassium-rich endolymph into perilymph are thought to be responsible for producing meniere’s attacks. Initial excitation of the hair cells as a result of the increased potassium concentration, Subsequent paretic phase is thought blockade of neurotransmitter release. Healing of the rupture allows restitution of the chemical composition of the endolymph & perilymph resulting in termination of the attack& improvement in vestibular & auditory function. The gradual deteriotion in inner ear function result from the effects of repeated ruptures. Clinical manifestations Recurrent attacks of spontaneous vertigo with nausea vomiting,attack are herald by lateralized low frequency hearing loss,tinnitus &aural fullness. Following onset ,the vertigo typically increases in intensity over a perioid of minutes then usually lasts for several hours.The hearing impairment &tinnitus may persist for days.Patient may have postural imbalance for several days. Typical attack has three phase;Irritative phase; nystagmus horizontal,beat towards the affected ear. Paretic phase; nystagmus beats away from the affected ear,last for several hours.Recovery phase ;nystagmus towards again affected side. In the early stage of the disease ,most patients are well between the attacks.As the disease progress ,patients may have persistent hearing loss,tinnitus&postural imbalance. Later stage of disease,some patients develop drop attacks(tumarkin or otolithic crises).The patient drops to ground without warning(patient experience some external force pushed to the ground.)
  • 2. Diagnosis of meneire’s disease: American Academy of Otolaryngology –head & neck surgery has published diagnostic guidelines for Meneire’s disease. Definite Meneire’s disease;two or more spontaneous attack of vertigo(each lasting 20minute or Longer)Hearing loss documented by PTA at least one occasion,tinnitus or aural fullness on the affected side. Probable Meneire’s disease;two or more spontaneous attack of vertigo with unilateral loss,tinnitus, Or aural fullness all at same time. A possible meneire’s disease;two or more spontaneous attack of vertigo,no auditory symptom during attack. In early stages of Meniere’s disease,vestibular &auditory function tests are often completely normal between attacks.A fluctuating low-frequency sensorineural hearing loss may be seen & is suggestive of the diagnosis of the early stage of the disease. As the disease progresses,all frequencies are affected resulting in a flat sensorineural hearing loss that is at least moderate in severity. Electrocochleograpgy; most sensitive & specific for meniere’s disease when tone-burst &click stimuli are used. Recorded transtympanically at the promontory. Giving 4gm of nacl for 3days prior to the electrocochleogram may increase the sensitivity. Management options: aim to decrease the production or accumulation of endolymph.Strict sodium restriction (so that uninary sodium is less than 50mmol/day) &diuretic can be effective in reducing the frequency of vertigo. Surgery; Endolymphatic sac surgery,selective vestibular neurectomy.labyrinthectomy with cochlear implantation. Recently intra tympanic inj. Of gentamycin may be effective to control severe intractable vertigo in most patients. Outcomes &complications; the natural history of meniere’s disease is variable.Attacks may occur days ,months ,even year apart, with little or no warning. In most patients only one ear is affected in early stage of disease, unfortunately the second ear involved in about half of the patients . Treatment of meniere’s disease(p 3798) The treatment of meniere’s disease should be preceded by diagnosis on the basis of strict criteria& after exclusion of retrocochlear pathology.
  • 3. 1)General measures:Level of anxiety correlates with the severity of symptoms in the patients with Meniere’s disease,it is postulated that stress may contribute via autonomic mechanisms in the genesis of endolymphatic hydrops. Increase prevalence for both inhalant & food allergies in patients with meniere’s diseae& it has been suggested that allergy immunotherapy & food elimination may be benefit in these cases. 2) Diet: to restrict salt intake to 1mg or 1.5 -2mg /day in order to address endolymphatic hydrops. 3)Drug therapy:Drug therapy for Meniere’s disease may include, a)Acute vestibular symptoms suppression by anticholinergic ,antihistaminic,calcium channel antagonist. b)Drug that aim to influence endolymphatic hydrops which include diuretics & betahistine. c)Suppression of immunological reactions with steroids or methotrexate. d)Deastruction of the vestibular end organ by intratympanic injection of aminoglycosides. Diuretics may be effective in the long term control of vertigo but not of cochlear symptoms. Dyazide has been reported as effective in controlling vertigo. Betahistine is a histaminic analogue with weak agonistic of both H1 & H2 ,moderate antagonistic action of H3 histaminic receptors. a) A reduction of the symmetric functioning of the vestibular end organ. b) Improved microvascular circulation in the stria vascularis of the cochlear. c) Inhibition of the activity in the vestibular nuclei. d) Less alertness effects on alertness through cerebral H1 receptors. Suppression of immunogical reaction:oral recommended treatments include high doses of prednisolone for one month with slow tapering over 4 to 6 months. Intratympanic injection of aminoglycoside.